Drug intelligence / Profile preview

erythrosine

Development stage
Unknown
Lead developer
Sigma Aldrich
Modality
Small Molecules
Administration
Topical, Oral
01

Overview

Erythrosine is a synthetic cherry-pink organoiodine compound primarily utilized as a food colorant (FD&C Red No. 3) and a biological stain. In clinical dentistry, it is widely employed as a diagnostic disclosing agent to visualize dental biofilm (plaque). Beyond its use as a dye, erythrosine acts as a potent photosensitizer in antimicrobial photodynamic therapy (aPDT). When activated by specific wavelengths of light (typically 430-550 nm), it undergoes intersystem crossing to a triplet state, transferring energy to molecular oxygen to generate reactive oxygen species (ROS), predominantly singlet oxygen. This oxidative process induces membrane disruption and cell death in bacteria and fungi, making it effective for treating periodontitis, root canal infections, and oral candidiasis. Additionally, research indicates it can act as an inhibitor of carbonic anhydrase isoenzymes.

Brand names
Erythrosine B
Other names
Red No. 3Acid Red 51TetraiodofluoresceinErythrosin
02

Targets

CA (Carbonic anhydrase)CA1 (Carbonic anhydrase 1)CA2 (Carbonic Anhydrase 2)

Beyond the preview

Go deeper on erythrosine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on erythrosine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call